Koneksa Solutions

Better Measurement. Clearer Evidence.

Designing How Clinical Evidence is Generated

Koneksa delivers integrated solutions across the measurement lifecycle, from strategy and endpoint design to data capture, signal detection, and regulatory-ready evidence.

Talk to an Expert
Clinical Evidence

More Data Doesn’t Solve the Measurement Problem

Clinical trials generate more data than ever, yet critical decisions remain uncertain. The issue is rarely the therapy. It is how its effects are measured. Endpoints are often shaped by convention. Data is collected across fragmented systems. Analysis comes too late to influence what matters most.

​More data alone does not solve this problem. Without a measurement strategy grounded in disease biology and clinical intent, variability increases, signals are diluted, and meaningful treatment effects can be missed.

Data ManagementWithout a measurement strategy grounded in disease biology and clinical intent, variability increases, signals are diluted, and meaningful treatment effects can be missed.
Read why measurement strategy must come first

A Measurement-First Approach to Evidence Generation

Koneksa applies a measurement-first, disease-led approach to clinical development, designing how outcomes are defined, captured, and interpreted from the start.

We begin with disease biology and therapeutic intent: identifying what should be measured, then designing integrated strategies that combine physiological, clinical, and digital signals to capture meaningful change over time.

​Data collection runs on infrastructure built for reliability and real-world use at scale. Signals are integrated across measures and time, not treated as isolated streams, and advanced analytics reduce variability, clarify true effect, and surface insight during execution. Learning evolves in real time and carries forward across studies, strengthening evidence across development programs.

Advancing
Digital
Measurement in Clinical Trials

Sensor-based digital health technologies are creating new opportunities to capture continuous, real-world evidence in clinical trials, but successful implementation requires more than deploying devices.

This publication from the eCOA Consortium explores how sponsors can design measurement strategies that balance scientific rigor, participant burden, operational feasibility, and data integrity. Learn best practices for integrating digital measures into clinical development to improve compliance, strengthen signal interpretation, and generate more decision-ready evidence. Read the framework

Solutions that Clarify Signal and Accelerate Evidence

Koneksa’s solutions are designed to work together across the measurement lifecycle, aligning strategy, data capture, and interpretation to generate clearer, more reliable clinical evidence.

Clinical Optimization

Measurement Strategy + Endpoint Design

Define what to measure and why it matters

We design biologically grounded measurement strategies and endpoints aligned to disease biology and clinical intent to capture meaningful change from the start.​

Explore More
Digital Endpoints

Signal Detection + Interpretation

Turn complex data into interpretable insights

We apply advanced analytics and modeling to integrated datasets to reduce variability and clarify true treatment effects.

Explore More
Data Management

Clinical Trial Measurement + Enablement

Capture high-quality data with precision and consistency

We enable integrated, multi-modal data capture across clinical trials to ensure high-quality, patient-centric data collection at scale.

Explore More
Flexible Biometric Engagement Models

Integrated Evidence Generation

Translate insights into regulatory-ready evidence.

We deliver integrated biometrics and regulatory strategies to transform clinical data into high-quality, decision-ready evidence.

Explore More

A Different Way to Generate Evidence

graph

Measurement strategy first,
not tool selection

data

Patient-Enriched Trial Design

magnify

Improved Signal Detection and Statistical Power

people

Greater Study Participant Engagement

Ensuring every component works together to generate clearer, more interpretable clinical evidence.

Designed for Complexity. Proven in Practice.

Koneksa’s approach is applied across real-world clinical programs, where measurement strategy, data capture, and interpretation must work together to generate reliable evidence.

Explore how this approach is put into practice across studies, therapeutic areas, and scientific research.

30
+
Validated
Measures
100
+
Implemented
Assessments
50
+
Studies
Supported
5
+
Therapeutic
Areas

Flexible Engagement Across
the Clinical Lifecycle

Koneksa partners across the clinical lifecycle, supporting both sponsors and CROs in strengthening how evidence is designed, generated, and interpreted.

Our role remains consistent, aligning measurement strategy, data capture, and analysis to improve decision-making, while adapting to where and how we integrate within each program.

Digital Endpoints

For Sponsors

Design measurement strategies that clarify treatment effects earlier, reduce development risk, and strengthen confidence in clinical decisions across programs.

​From endpoint design through evidence generation, we help ensure what is measured reflects what matters most and supports clearer, more confident decisions.

Data Management

For CROs

Enhance trial delivery with integrated measurement science that improves signal clarity, strengthens endpoints, and elevates the value delivered to sponsors.

​​We complement CRO execution by aligning measurement strategy, data capture, and interpretation to support more reliable outcomes.

Measurement Strategy Insights

Cardiovascular measurement overview showing Koneksa's framework across cardiac physiology, mobility, imaging, biomarkers, and PROs
Cardiovascular MeasurementFact Sheet

Cardiovascular Measurement

Pain clinical trial endpoints case study cover showing multi-measure pain recovery study from Koneksa
Revealing the Path of Pain RecoveryCase Study

Revealing the Path of Pain Recovery

Pain measurement evidence snapshot comparing under 1% pain drug approval rate to 6.5% for novel drugs
Evidence Snapshot: PainFact Sheet

Evidence Snapshot: Pain